|1.||Kitahara, M: 1 article (06/2000)|
|2.||Tsuruzoe, N: 1 article (06/2000)|
|3.||Naitoh, T: 1 article (06/2000)|
|4.||Yotsumoto, T: 1 article (06/2000)|
06/16/2000 - "One-week administration of SDZ CPI 975 caused neither cardiac nor hepatic hypertrophy. "
06/16/2000 - "We investigated the effect of two types of carnitine palmitoyltransferase I inhibitors, ethyl 2-(6-(4-chlorophenoxy)hexyl)oxirane-2-carboxylate (etomoxir) and (R)-3-carboxy-N,N, N-trimethyl-2-¿[hydroxy(tetradecyloxy)phosphinyl]oxy¿-1-propana minium hydroxide (SDZ CPI 975), on cardiac and hepatic hypertrophy in ddY mice. "
|2.||Cardiomegaly (Heart Hypertrophy)
|2.||Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)